MHRA – Page 184 – Pharma.Tips

Microbial Limits Failure in dental paste filling: GMP investigation steps with CAPA

Investigating Microbial Limits Failure in Dental Paste Filling: A GMP Approach with CAPA Microbial limits failures in dental paste filling are a significant concern within pharmaceutical manufacturing, particularly when it…

Pet Failure after packaging change: manufacturing vs lab root cause assessment

Root Cause Assessment for Pet Failure Following a Packaging Change in Pharmaceuticals The pharmaceutical manufacturing industry often faces challenges when packaging changes are implemented, leading to unexpected quality issues in…

Hold Time Bioburden Rise after supplier change: GMP documentation for FDA/EMA/MHRA review

Investigation of Increased Bioburden Hold Times Following a Supplier Change Bioburden testing is pivotal in ensuring the quality and safety of pharmaceuticals, particularly in sterile environments. After a recent supplier…

Viscosity Drift at accelerated stability: packaging compatibility and shelf-life justification

Investigating Viscosity Drift During Accelerated Stability Testing: Ensuring Packaging Compatibility and Shelf-Life Justification Viscosity drift observed during accelerated stability tests can indicate underlying issues impacting product quality and regulatory compliance…

Tube Leakage Complaint after supplier change: QMS trending and complaint handling expectations

Addressing Tube Leakage Complaints Following Supplier Changes in Pharmaceutical Manufacturing In the pharmaceutical manufacturing environment, changes in suppliers can lead to unforeseen issues, including product complaints such as tube leakage.…

Content Uniformity Failure during method transfer: sampling and mixing controls for QA review

Addressing Content Uniformity Failures during Method Transfer: A Comprehensive Investigation Guide Content uniformity failures during method transfer can present significant challenges in pharmaceutical manufacturing, especially in quality assurance. Such failures…

Viscosity Drift during method transfer: GMP documentation for FDA/EMA/MHRA review

Understanding Viscosity Variations during Method Transfers: A Guide for Pharmaceutical Professionals Viscosity drift during method transfer can compromise product quality and regulatory compliance. It may arise from process modifications, equipment…

Assay Oos after supplier change: manufacturing vs lab root cause assessment

Investigating Assay OOS After a Supplier Change: A Comprehensive Approach In the realm of pharmaceutical manufacturing, an Out of Specification (OOS) result, especially concerning assays, can trigger significant concern and…

Pet Failure during bulk hold: GMP investigation steps with CAPA

Steps for Investigating Pet Failure During Bulk Hold in Pharmaceutical Manufacturing In the realm of pharmaceutical manufacturing, encountering a Pet failure during bulk hold can lead to significant challenges, impacting…

Preservative Miscalculation after supplier change: investigation steps with CAPA evidence

Addressing Preservative Miscalculation Following a Supplier Change: A Detailed Investigation Guide In the complex world of pharmaceutical manufacturing, a preservative miscalculation can lead to significant quality control challenges, especially after…

Fill Weight Variability in dental gel manufacturing: QMS trending and complaint handling expectations

Addressing Fill Weight Variability Issues in Dental Gel Production: A Structured Investigation Approach Fill weight variability in dental gel manufacturing is a critical issue that can lead to non-compliance with…

Texture Grittiness Complaint during bulk hold: sampling and mixing controls for QA review

Investigating Texture Grittiness Complaints during Bulk Hold: Sampling and Mixing Controls for QA Review In pharmaceutical manufacturing, quality complaints can significantly impact production schedules and product integrity. One ongoing challenge…